Pak appoints new prosecutor in Mumbai attack case

September 13, 2013

Mumbai_attackBishkek, Sep 13: Pakistan has informed India that it has appointed a new prosecutor to probe the 2008 Mumbai terror attack and will send a Judicial Commission to the country on September 23 to cross-examine witnesses in the case, meeting India's demand for progress in the investigations.

External Affairs Minister Salman Khurshid today said he was told about Pakistan's decision during an informal chat he had with Sartaj Aziz, the advisor to Pakistan Prime Minister on Foreign Affairs, here in the capital of Kyrgyzstan last night.

"We had an informal chat. We had a good chat. We have been together here," he said.Aziz and Khurshid, who are here for the Shanghai Cooperation Organisation (SCO) Summit, shared the same table over dinner.

Talking to reporters, Khurshid said that he was informed by Pakistan about a new prosecutor been appointed in the Mumbai attacks case.

"One emphasis that we have legitimately given is the public sentiment on the slow progress of the Mumbai incident. We want accountability for the Mumbai incident," he said.

"We have been told that a Judicial Commission will come to India on September 23 to cross examine witness in connection with 26/11. Another thing is that a prosecutor has been appointed."

The appointment of a new prosecutor to handle the 26/11 Mumbai attack case came as the previous prosecutor Chaudhry Zulfizar Ali was shot dead by unidentified gunmen in May.

Pakistan's decisions came as India has been demanding action against perpetrators of the Mumbai attacks and steps to curb activities of anti-India militant leaders like Jamaat-ud-Dawah chief Hafiz Saeed.

On whether roadblocks for discussion between Prime Ministers of the two countries later this month in New York have been removed, Khurshid said, "We told him that in view of the wish of the people for positive talks, there has to be a conducive atmosphere. Whenever high-level talk process is on, atmosphere should be good."

"If there is a lack in atmospherics, there is a need to correct things to proceed. But if things are not sorted then there difficulties are faced," he said.

Pakistan has been pushing for a meeting between Prime Minister Nawaz Sharif and his Indian counterpart Manmohan Singh on the margins of the UN General Assembly in New York later this month. India has been non-committal on the meeting.

Relations between the two countries soured after five Indian soldiers were killed in an attack by Pakistani troops on the Indian side of the LoC on August 6. Both sides have accused each other of violating the truce along the LoC.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 1,2020

New Delhi, Jun 1: India's COVID-19 tally on Monday witnessed its highest-ever spike of 8,392 cases, while 230 more deaths related to the infection were also reported in the last 24 hours, according to the Union Ministry of Health and Family Welfare (MoHFW).

The total number of coronavirus cases in the country now stands at 1,90,535 including 93,322 active cases, 91,819 cured/discharged/migrated and 5,394 deaths.

COVID-19 cases in Maharashtra continue to soar with the number reaching 67,655. Tamil Nadu's coronavirus count stands at 22,333 while cases in Delhi the number has reached 19,844

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

New Delhi, Jun 30: With a spike of 18,522 COVID-19 cases in the last 24 hours, India's coronavirus count now stand at 5,66,840, said the Union Health and Family Welfare Ministry on Tuesday.

According to the Ministry, 418 deaths due to COVID-19 were reported in the last 24 hours. The number of deaths in the country now stands at 16,893.

There are 2,15,125 active coronavirus cases in the country while the number of cured/discharged patients stands at 3,34,821 and one patient migrated.

As per the Ministry, Maharashtra is the worst-hit state with regard to the COVID-19 cases and has reported 1,69,883 cases, including 73, 313 active cases 88,960 cured/discharged patients and 7,610 fatalities.

Tamil Nadu has a total of 86,224 cases including 1,141 deaths. Delhi's COVID-19 count stands at 85,161 cases and 2,680 fatalities.

The total number of samples tested up to 29 June is 86,08,654 of which 2,10,292 samples were tested yesterday, informed the Indian Council of Medical Research.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.